NCT02710994View on ClinicalTrials.gov

Pharmacodynamics and Safety of CDFR0209

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

March 31, 2015

Conditions
Stomach UlcerGastroesophageal Reflux
Interventions
DRUG

CDFR0209

Immediate release omeprazole 40 mg and sodium bicarbonate 1,100 mg

DRUG

Losec

Losec 40 mg

Trial Locations (1)

443-380

Ajou University Medical Center, Suwon

All Listed Sponsors
collaborator

CTC Bio, Inc.

INDUSTRY

lead

Ajou University School of Medicine

OTHER

NCT02710994 - Pharmacodynamics and Safety of CDFR0209 | Biotech Hunter | Biotech Hunter